Safety and Efficacy of Etanercept in Patients With Psoriasis Who Failed to Respond to Other Biologic Treatments
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate safety and efficacy of etanercept in patients with
psoriasis who had an unsatisfactory response to adalimumab and infliximab.